We feel BEARISH on the markets.
“It’s waiting that helps you as an investor, and a lot of people just can’t stand to wait.” – Charlie Munger
Hansa Medical AB is a Sweden-based research company focused on the development of biopharmaceuticals and diagnostics within inflammation.
Fair value: 187.5 SEK
Premium: 6%Average yearly return: 62%
Yield: N/A
Outperformer
On May 31, 2017:
Increase of number of shares and votes in Hansa Medical AB (publ)
No comments:
Post a Comment